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Summary. Contraception in women over the age of 40 has received little
attention, and accurate data are not readily available. This paper compares
data from surveys from the United States and five major countries in Western
Europe. Consideration is given to the possible effect on these women of the
threat of reduced availability of suitable contraceptive methods as a result of
current developments within society at large. This is of particular importance
as it appears that, especially in Western Europe, contraception is under-
utilized in this age group. The benefits and risks of various methods of
contraception are discussed. Use of the pill by older women remains
controversial. Misconceptions about pill use and the IUD seem to be
widespread among women of all ages.
Introduction
Little is known about contraception in women over the age of 40. Population surveys
usually stop at the age of 44 or 45, ignoring the 5 years (on average) of remaining
reproductive life. It is remarkably difficult to obtain information on the methods of
contraception used by older women, and nearly impossible to find out why a
particular method was chosen (WHO, 1981). That scant attention has been paid to
this age group can also be seen in the lack of an age-specific range of contraceptive
methods for women over 40.
In the United States, no national contraceptive prevalence survey since the 1965
National Survey of Family Growth has included women aged 45 or over, although
the Cancer and Steroid Hormone Study carried out by the US Centers for Disease
Control in 1982 (CDC, 1983) provided some information about the fecundity status
of US women over 44. In fact, much of the information that is at present available
comes from data collected for other purposes.
The lack of information is particularly striking because of the attitudes and
behaviour of this age group. Women over 40 are today showing a greater interest in
contraception; they are the women whose attitudes were influenced by the sexual
revolution of the 1960s. They do not fit the popular image of the middle-aged mother
who has fulfilled her role of bearing children and no longer takes an interest in sex.
Moreover, there is evidence to indicate that an increasing number of couples are
intentionally choosing to have their children at a later stage in their lives, as the result
of changing social and economic trends in several Western countries (Francis, 1985).
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Yet, even as planning of births increasingly extends into older age ranges, the
availability of suitable contraception is under growing threat as the result of the cost
of litigation following mishaps with some contraceptive methods, the negative
publicity being given to some methods, and the consequent decreasing enthusiasm for
research and development within the industry.
Data and methods
Data used for Western Europe are taken from the five-country survey of 8180 women
conducted by the International Health Foundation. The survey, carried out in 1984
and 1985, covered women between 15 and 45 years of age in Italy, France, Great
Britain, Spain and the Federal Republic of Germany, and the results have been
published separately for each country (Riphagen, van der Vurst & Lehert, 1984,
1985a,b, 1986a,b). In this paper, only data on women between 41 and 45 are used,
unless stated otherwise. In these European countries, women of 41-45 years of age
represent, on average, 15% of all women aged 15-45. In the International Health
Foundation data they numbered 961, 13% of the total.
The samples used—which, with the exception of Spain, were not purely random—
compared in age, marital status and level of education to the national population of
each country were found to be representative (Riphagen et al. 1984,1985a,b, 1986a,b).
Contraceptive use rates for the total populations were compatible with those of
countries for which recent, reliable data are available (World Fertility Survey, 1981,
1982; OPCS, 1985; INE, 1986).
In view of the relatively small size of the European subsamples, the methods used,
and the fact that the studies were not aimed at this age group, the data should be
considered only as indicators of attitudes and opinions, which are nonetheless
interesting in their implications.
For the United States, the data came from women between the ages of 40 and 54,
although in several cases statistics are presented for women between 40 and 44. Data
were not derived from a sample specifically obtained for this study but were taken
from previously published data, particularly the 1982 National Survey of Family
Growth (NSFG) (Pratt et al., 1984) and the 1982 Market Survey, a nationally
representative survey carried out by a large pharmaceutical company (Forrest &
Henshaw, 1983).
Population at risk
In 1982 there were approximately 13 million American women aged 40-49, most of
them sexually active, and many still able to conceive (Pratt et al., 1984). Of those
women who are exposed to the risk of pregnancy (i.e. sexually active and neither
sterile nor pregnant), 20% are not using any method of contraception (Table 1). This
is a higher percentage than in any other age group, including teenagers (Forrest &
Henshaw, 1983, Table 5 recalculated).
Between 20% and 30% of women aged 40-44 have had a hysterectomy; the exact
percentage depends on the data source (Table 2). The prevalence of hysterectomy
varies by region, being lowest in the north-east and highest in the south (Walker &
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Table 1. Percentage of US women exposed
to the risk of pregnancy who use no method
of contraception, by age (NSFG, 1982)
Age (years)
15-19
20-24
25-29
30-34
35-39
40-44
% using no method
18
12
8
9
16
21
Source: Pratt el al. (1984).
Jick, 1979) (Table 3). Natural menopause has occurred in about 3% of women aged
40-44,11 % of those aged 45^9, and 43 % of those aged 50-54. This is in addition to
those with a surgical menopause (Table 4). Thus, almost 30% of women aged 50-54
have not yet passed menopause.
Approximately 10% of women in the 40-44 age group are not at risk of
unintended pregnancy because they are either pregnant, post-partum, seeking
pregnancy or not sexually active. Corresponding figures are not available for the
45-54 age group. Figures for women in the five European countries under
consideration (Table 5) show that the percentage of women between the ages of 41
and 45 who are not at risk because they are either pregnant or seeking pregnancy
ranged from 0% (Federal Republic of Germany) to 5% (Italy). The corresponding
figure is about 1-5% for American women between 40 and 44 years of age (Table 4).
Sexually non-active women in the European countries ranged from 1 % (Italy) to
21% (Spain), but this figure is somewhat dubious; the number of women who are not
sexually active is quite low, with the exception of Spain.
This is not an isolated finding, for, though few data are available for Spain, all
Table 2. Prevalence of hysterectomy in US women
aged 40-54
Study
NSFG*
CASH (controls)t
CPHAJ
Upstate NY§
Year
1982
1981-2
1975
1982
40-44
21-8
201
28-4
151
Age (years)
45-49
30-9
31-5
24-3
50-54
28-3
30-8
25-9
Sources: * NCHS special computer run; f Cancer and Steroid
Hormones, FHI special computer run; t Commission on
Professional and Hospital Activities, Walter & Jick (1979);
§ Howe (1984), Nolan et al. (1982).
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Table 3. Prevalence (%) of natural and surgical menopause in the
United States, 1980-82
Menopause
Natural
Surgical
Total
N
NSFG
1982
40-44
30
21-8
24-8
794
Market survey
1982
40-44
180
Controls for CASH
1980-82
40-44
2-1
201
22-2
956
45-49
113
30-9
42-2
1503
study
50-54
430
28-3
71-3
1876
Sources: Special computer runs from NSFG and CASH.
other age groups in Spain also show a low percentage of sexual activity.
Unfortunately, the Encuesta de Fecundidad 1985 did not include questions on sexual
activity, thus rendering determination of the exposed population more difficult (INE,
1986). In the United States the percentage of those not sexually active is about 8% for
women between 40 and 44 years old (Table 4).
The percentage of those who stated they were infertile for reasons other than
contraceptive sterilization of one of the partners ranged from 7% (Italy) to 16%
(Federal Republic of Germany and France). The percentage for Italy, however, seems
to be low considering that early hysterectomies, estimated by van Keep,
Table 4. Percentage distribution of US women aged 40-54 not at risk of unintended
pregnancy, by reason, 1980-82
Reason
Contraceptive sterilization
Male
Female
Menopausal
Natural
Surgical
Pregnant
Post-partum
Seeking pregnancy
Not sexually active
Total not at risk
Total at risk
N
Market survey
40-44
17-5
234
180
0-5
10
7-0
74-2*
25-8
1102
NSFG
40-44
13-3
26-4
30
21-8
01
0-2
14
8-6
74-8
25-2
794
40-44
21
201
0-3
956
Controls for
45^t9
113
30-9
00
1503
CASH
50-54
430
28-3
00
1876
* Includes 6-8% 'infertile' and rounding errors.
Sources: as Table 3.
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Table 5. Fertility position (%) for women aged 41-45 in five Western
European countries
Italy France Great Britain Spain West Germany
Postpone pregnancy
No (more) children
Pregnant (or trying)
Infertile*
Not sexually active
13
74
5
7
1
14
63
2
16
5
5
81
1
11
2
11
52
2
14
21
13
68
0
16
3
* Excluding contraceptive sterilization.
Source: Riphagen et al. (1985, 1986).
Wildermeersch & Lehert (1983) at 4 1 % for this age group in these countries, are
included.
Thus, in the United States nearly 70% of women in the 40-44 age group and
perhaps 30% of those aged 45-54 are still in need of contraception. The European
figures for the 41^5 age group are higher, ranging from 63% (Spain) to 87% (Italy)
(Table 5).
In the absence of exact data, estimates regarding the decline of fecundity with age
in modern populations (i.e. using contraception) vary from 23-40% natural infertility
at age 40 up to 80% natural infertility at age 45 (Bongaarts, 1982; Gray, 1979). In the
European data, the percentage of women who claimed to be infertile is, by any
standard, lower than these estimates. This discrepancy reflects the difference between
projections based on retrospectively determined, age-specific infertility rates applying
to whole populations, and the reality of the individual woman whose age is
approximately 40 at present.
There is evidently no way for the individual woman to know with certainty that
she is no longer fecund on the basis of age alone. Therefore, except for those who have
had a hysterectomy or been sterilized, women must regard themselves as exposed to
the risk of pregnancy.
Pregnancy
Although pregnancy is not very common in women over 40, a fair percentage of
the women questioned in the five-country European survey did not exclude the
possibility of another pregnancy, though they expressed the desire to 'postpone
another pregnancy' (Table 5). This seems to indicate that childbearing at a more
advanced age is not considered out of the question, with the implication that
reversible methods of contraception are certainly needed by women over 40.
However, a pregnancy can be particularly devastating to an older woman. A
woman over 40 will often already have grown children, a pregnancy may prove
emotionally unsettling, and the risk of birth defects if she carries the pregnancy to
term is much greater than at a younger age.
Furthermore, maternal mortality and morbidity are high for women in their 40s.
American data show that although there were only 20 such deaths in 1979 (40-44,15;
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Table 6. Mean interval (months) since last
live birth for US women aged 40-49, 1980
Birth progression
First to second
Second to third
3-4
4-5
5-6
6-7
7-8 +
40-44
105
125
118
109
95
82
57
45-49
130
159
164
149
127
124
77
Source: Vital statistics of the United States, 1980,
Vol. 1, Natality. USDHHS.
45-49, 5) of women 40 and older, the maternal mortality ratios in women aged 40-44
and 45-49 (NCHS, 1984b) were respectively eight and fifty times those in women in
their 20s.
Births
There is evidence that the mean age at birth of last child is about 40 (Gray, 1979;
Jansen, 1984). In the US in 1979, women of 40-44 had 24,461 births and 18,680
abortions. Of the births, 1904 were first births, a birth rate of 3-9 per 1000 women aged
40-44 (Ventura, 1982). Most of these births follow a long birth interval: 56% of births
to women aged 40-44, and 67% of those to women aged 45-49, follow a birth interval
of more than 6 years (NCHS, 1984a). The lower the birth order, the longer the interval
(Table 6).
Contraceptive use
Table 7 shows contraceptive use for women aged 41-45 in the five-country survey of
Western Europe, compared with the wider, 15-45 age group. Figures for
contraceptive use by American women aged 40-44 are given in Table 8; sterilization
figures are contained in Table 9.
Rhythm and withdrawal
The use of no method or of rhythm or withdrawal is higher among older women
(41-55) than among all women (15-45) (Table 7) in Italy (84% and 56%, respectively),
France (46% and 36%) and Spain (52% and 42%). The NSFG study of American
women aged 40-44 does not give separate figures for no method or withdrawal, but
for use of the rhythm method, or some variation thereof, the figure quoted is 12%
(Table 8). The NSFG figure is comparable to those presented for Italy, France and
Spain; other studies show a smaller percentage. The rates for Great Britain are 13%
for women aged 41-45 (14% for those 15^45) and 25% (43%) in West Germany. It
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Table 7. Contraceptive method use (%) by exposed women, by age, in five
Western European countries
Method
Age 41-45
No method
Rhythm
Withdrawal
Barrier methods
IUD
Pill
Sterilization
Age 15-45
No method
Rhythm
Withdrawal
Barrier methods
IUD
Pill
Sterilization
Italy
41
14
29
12
4
0
0
30
12
14
23
15
6
(1)
Spain
31
10
11
23
14
8
3
26
7
9
23
13
19
3
France
16
13
17
9
23
10
12
24
6
6
9
19
31
5
Great Britain
7
0
6
23
7
3
54
10
1
3
17
8
38
23
West Germany
8
13
4
13
7
19
36
19
14
10
7
10
33
7
Source: Riphagen et al. (1985, 1986).
Table 8. Reversible contraceptive methods used by US women (%)
aged 40-55, 1982 and 1984
Pill
IUD
Diaphragm
Condom
Rhythm
Other*
Total
N
NSFGf
198?1 /OX
40-44
3-4
19 4
12-9
34-8
12-3
16 9
1000
7969
Market SurveyJ
1987
40-44
15-6
12-5
94
34-4
6-3
21-9
1000
California Medicaid§
40-44
6-2
40-4
12-6
38-2
2-6
1000
3412
1984
45-55
114
31-3
9-5
43-8
40
1000
1692
* Market Survey: 15-6 spermicides, 6-3 withdrawal; NSFG: not specified.
Sources: f Pratt et al. (1984); t Forrest & Henshaw (1983); § Aved (1985).
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Table 9. Prevalence (%) of surgical contraception among
US couples, wife aged 40-44, 1982
NSFG* Market Surveyf
Woman sterilized
Man sterilized
Total
N
26-4
13-3
39-7
7969
23-4
17-5
40-9
10,000
Sources: * Special computer run; f Forrest & Henshaw (1983).
appears that older German women practise the 'safest' contraceptive behaviour of
those surveyed.
The figures are not entirely reassuring since the increase in menstrual irregularities
as women approach the menopause makes the rhythm method difficult to use.
Despite the fact that decreased coital frequency and fecundity in older women may
make rhythm more acceptable, women over 40 are unlikely, on the whole, to be using
this method unless they have been successful with it before. And, on account of the
high incidence of maternal morbidity and birth defects in this age group, less reliable
methods cannot be recommended for women unwilling to consider abortion as a
back-up measure.
Sterilization
The contrast between use of sterilization, a no-risk method and the high-risk
methods described above is striking. The European data show that where use of high-
risk methods is common, use of sterilization is rare (Table 7).
The sterilization rate for women aged 41-45 is exceptionally high for Great
Britain (54%) and slightly less so for West Germany (36%). In contrast, sterilization is
extremely low, or non-existent, in Italy (0%) and Spain (3%), and relatively low for
France (12%), while use rates for high-risk methods in these countries were 84%, 52%
and 36%, respectively. Overall, in the five countries the figure for sterilization is 21 %.
Sterilization is illegal in Italy. The total hysterectomy rate in that country for women
between 40 and 70 is 15-5%, however, as compared to 11-4% for the total sample of
six European countries studied by van Keep et al. (1983).
In the United States, sterilization is by far the most commonly chosen method
among women aged 40 and over, in the form of tubal ligation or partner's vasectomy,
with about 40% of all women aged 40-44 being protected by contraceptive
sterilization of either themselves (25%) or their partners (15%) (NSFG special run;
Forrest & Henshaw, 1983). Table 9 does not show when these sterilizations were
performed, but about 45,500 American women aged 40-44 had tubal ligations in 1982
(7% of 650,000 tubal ligations: Grubb et al., 1985).
Sterilization is the most reliable method of contraception, and carries only slight
surgical risk (primarily in the form of anaesthetic accidents), greater among older than
among younger women, but with an overall risk of death about the same as with the
IUD or abortion alone (Potts, 1979). Thus sterilization seems to be the ideal method
for women who do not wish to have any more children, and appreciation of this fact
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can be seen in the use figures for the United States, Great Britain and the Federal
Republic of Germany. Older women are on the whole less likely than younger women
to regret having been sterilized (Liskin & Rinehart, 1985). However, in view of present
trends in childbirth at older maternal ages, particularly in the context of second
marriages or unions, women may be more reluctant in future to opt for sterilization.
Reversible methods
Only 25% of American women aged 40-44 (or their partners) use a reversible
method of contraception: condom or diaphragm (barrier methods), the pill or the
IUD. In the five European Countries, 32% of the women surveyed use reversible
methods, more than the 21% who have opted for sterilization. Reversible methods
are still much more widely used than in the US, not only in countries with high
sterilization rates, such as Great Britain (33% reversible methods) and West Germany
(39%), but also in those with low sterilization rates, such as Spain (45% reversible
methods) and France (42%); the only exception is Italy, which shows a zero
sterilization rate and a barrier method use rate of 16%, as compared to a use rate of
84% for high-risk methods.
Barrier methods. Among American women surveyed, the most popular method
was the condom, used by 30-40% of those in the 40-44 age group using reversible
methods. Over 40% of the older women in the age group under discussion use this
method.
Condoms are liable to be regarded as unsatisfactory because, for example, they
are 'less than aesthetic and often inconvenient' (Greenblatt, Nezhat & McNamara,
1979). They are rarely mentioned as appropriate contraception for older women and
are 'seldom prescribed and used today' (Stone, 1976). Moreover, the method suffers
from being perceived as unreliable (Table 10). Among European women surveyed in
the 41-45 age group, only 15% used barrier methods, and 48% of this group stated
that the reliability of the condom was doubtful; a further 13% found it frankly
unreliable and 15% had no idea on the subject. The method was seen as reliable by
only 24% of respondents, and by still fewer among the general group of women of all
ages surveyed.
Nevertheless, there are advantages to the condom: it poses no health risk, it is
available without prescription, and it protects against various infections. Further-
more, what are seen as disadvantages for younger women may constitute advantages
for the older woman. Thus, the method is coitus-dependent, which means that while
continuous protection is not provided, neither is continuous risk or cost. And what
may be an unacceptably high failure rate among younger women is much lower
among older women, who exhibit more consistent use of the method and lower
fecundity. One possible disadvantage is that condom use may exacerbate problems of
male impotence or ejaculatory difficulty which increase with age (Beard, 1979;
Bowen-Simpkin, 1984).
Among American women using reversible methods, the diaphragm was
considerably less popular than the condom, with a use rate of 9-13% in the 40-44 age
group. Vaginal laxity or cervical deformities resulting from childbirth may reduce the
efficiency of the diaphragm for older women (Beard, 1979; Bowen-Simpkin, 1984).
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Table 10. Perceptions of reliability and safety in terms of health of contraceptive
methods (%), by women in five West European countries
Pill
15-19
All ages
41^45
IUD
15-19
All ages
41^*5
Condom
15-19
All ages
41-45
Reliable
42
53
47
32
32
26
14
20
24
Reliability
Doubt
45
34
33
40
45
44
60
55
48
Unreliable' No idea
2
4
3
4
7
9
12
12
13
11
9
16
24
16
21
14
13
15
Safe
9
8
5
12
18
20
27
38
41
Doubt
66
65
59
41
44
37
26
21
19
Safety
Unsafe
12
18
23
19
17
19
14
12
13
No idea
13
9
13
28
21
24
33
29
27
Source: Riphagen et al. (1985, 1986).
IUD. The three American surveys used differ somewhat in their estimates of the
proportion of US women aged 40-44 who use IUDs (Table 8). Among California
Medicaid patients (certainly not typical), the IUD is the most popular reversible
method, used by 40% of clinic clients. In the two national surveys, the NSFG shows a
19% use rate, the Market Survey only 12%.
Among European women surveyed, the mean use rate (Table 7) was a mere 11 %.
The highest rate per country was among French respondents (23%) with a rate of
14% for Spain, and very low rates of 4%, 7%, and 7% for Italy, Great Britain and
West Germany, respectively.
There is disagreement as to the appropriateness of intrauterine contraception for
older women. There are two major disadvantages to the IUD. The first is increased
risk of pelvic inflammatory disease and the subsequent possibility of infertility.
Assuming that older women are less at risk for contracting sexually transmitted
diseases and, therefore, pelvic inflammatory disease and have probably completed
their childbearing, this disadvantage becomes relatively unimportant.
The second disadvantage is bleeding and cramping, which may be exacerbated if
fibroids are present or if there is perimenopausal menorrhagia. But if patients are
adequately screened and have no initial bleeding problems, additional problems are
not to be anticipated, although there are no data to demonstrate this. An exception
might be insertion problems in women who have had previous cervical surgery
(Beard, 1979).
In the five-country survey there was a disturbingly high percentage of respondents
with misconceptions about the safety and efficacy of the IUD. In women in the 41-45
age group, 44% expressed doubts about its reliability, 37% doubts about its safety in
health terms, while a further 19% described the method as definitely unsafe (Table
10).
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Table 11. Percentage of all women aged 40-54
who currently take oral contraceptives
HANES II* Nurse studyt
1976-80 1976
Age % N % N
4(M4
45-49
50-54
4-4 (1-3)
6-2 (2-2)
2-5 (1-8)
282
201
79
6-4
5-1
3-8
1085
640
188
Sources: * Russel-Briefel et al. (1985); f Lipnick et al.
(1986).
However, the IUD is an excellent method of contraception for older women. It is
effective and convenient, and IUD-related problems are far less likely to occur, and to
be of less consequence, in older than in younger women.
Oral contraception. There is probably more controversy about pill use among
older women than about any other method. This concerns both how many older
women use the pill and whether or not they should use it. One complicating factor is
that new developments in oral contraceptives resulting in safer pills may have passed
by older age groups.
In the National Survey of Family Growth, only 3% of American women aged
40-44 using reversible contraception used the pill (Table 8); this was the least popular
method of contraception (Pratt et al., 1984). In the Market Survey, 16% of women
used the pill and it was third in popularity among reversible methods for older
women (Forrest & Henshaw, 1983).
The Health and Nutrition Examination Survey (HANES) Cycle II (Table 11)
found that 4-4% of all women aged 40-44 (i.e. not merely those using reversible
contraception) were taking oral contraceptives (Russel-Briefel, Ezzati & Perlman,
1985). And a survey of 121,964 nurses aged 30-55, based on a mailed questionnaire,
found that 6-4% of US nurses aged 40-44 were currently taking the pill (Lipnick et al.,
1986). These two studies also provide information on women aged 45 and older. The
HANES II study suggests that about 403,000 women over 40, and 29,000 over 50, are
using the pill.
Perceptions of the pill tended to be extremely negative. A Gallup poll carried out
in January 1985 on behalf of the American College of Obstetrics and Gynecology
found that 76% of American women saw substantial risks in using the pill, 31%
thought it caused cancer, and 64% (incorrectly) saw childbearing as a risk smaller
than or equal to taking the pill—opinions 'markedly inconsistent with the scientific
evidence' (Report of the Perceptions of the Pill Survey Group, 1987).
European figures for pill use were low (Table 7), only 6% for women aged 41-45.
Of the individual countries, only the Federal Republic of Germany had a sizable use
rate (19%). Rates in the remaining four countries are modest: 10% in France, 8% in
Spain, 3% in Great Britain and 0% in Italy.
Discrepancies between data relating to perceptions of reliability and of health
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safety are even more striking for the pill than for the IUD. Of the women questioned,
47% considered the pill reliable; 5% considered it safe. Three per cent of those
surveyed considered the pill to be unreliable; 23% said it was unsafe, and a sizable
percentage (33%) had doubts about pill safety. These perceptions are not limited to
the age group under discussion; there appears (Table 10) to be very little variation
with age.
Among gynaecologists, some believe that use of oral contraception is justified in
older women, provided that they are in good health and medically supervised
(Bowen-Simpkin, 1984; Connell, 1984; Friedman, 1974). Others, perhaps a majority,
would give qualified approval (Stone, 1976; Weisberg, 1985), and some feel that pill
use is almost never justified.
The controversy surrounding the advisability of oral contraceptive use by older
women reflects the incomplete understanding of the effects of pre- and post-
menopausal oestrogens and progestins; this is especially true of the newer
formulations. Women using contraceptive oestrogens have an increased risk of
cardiovascular disease morbidity and mortality. While postmenopausal oestrogens
reduce the risk of cardiovascular disease (Bush & Barrett-Connor, 1985), three large
cohort studies and many case-control studies have established beyond doubt that the
risk of myocardial infarction and stroke among women using the older oral
contraceptive formulations increases with age. Data are still lacking on the new
formulations.
In women over 40, the relative risk of myocardial infarction is four times greater
among pill users, and the relative risk of stroke is five times greater (Stadel, 1981).
Among non-smokers, however, the absolute risk remains quite small, even in this age
group, while the risk of maternal mortality and morbidity increases rapidly with age.
While the great majority of oral contraceptive deaths occur in women who smoke or
who are over 35, the normotensive, slim non-smoker can probably safely use oral
contraception if she is medically supervised. Furthermore, oral contraception
provides excellent cycle control and hormone replacement therapy at a time when
both of these are desirable (Bowen-Simpkin, 1984). Oral contraception may also
relieve undesirable symptoms of the menopause (Kase, 1976; Shargil, 1985).
There is some confusion about the role played by the progestin component
(Meade, Greenberg & Thompson, 1980). Injectable long-acting progestogens have
the advantage that they seem to have few metabolic side effects. But the disruption of
bleeding patterns may, in this age group, require a diagnostic curettage.
Older women are more likely than younger women to be taking oral
contraceptives containing relatively high oestrogen doses (Table 12). In a study of
Medicaid claims for prescriptions in Minnesota and Michigan in 1980, van de Carr et
al. (1983) report that 25-26% of Michigan women aged 35-49 were filing
prescriptions for pills containing 60+ /ig of oestrogen, compared with only 16% of
the total of oral contraceptive prescriptions. In Minnesota, the results were even more
striking: 39% of women aged 45-49 were using the highest dose oestrogen pills (24%
of those aged 35-39, 14% of those aged 40-44), compared with 14% of all women.
The authors suggest three reasons: (1) brand loyalty—that is, older women started pill
use earlier and continue with the same brand, to their obvious disadvantage; (2)
physicians concentrate on starting new users on low dose brands because of the
use, available at https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S0021932000017375
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 07:45:58, subject to the Cambridge Core terms of
Contraception in older women 139
Table 12. Percentage of women using highest
dose (60-150/xg oestrogen) oral contraceptives,
by age: Medicaid patients, 1980 (N= 81,968)
Michigan Minnesota
4(M4
45-49
All ages
% of all users aged 40 +
26
25
16
11
14
39
14
1-4
Source: van de Carr et al. (1983).
greater duration of future exposure; and (3) older women are more concerned about
pregnancy and therefore prefer the higher doses.
The authors considered the last reason to be the least likely, but the reasons are
clearly not thoroughly understood, and more research is called for.
Conclusions
In all the countries studied, reliability was an important factor in choice of
contraceptive method. In the US 20-25% of all the women studied chose sterilization
as a method of contraception. American couples are more likely to choose
sterilization than all other methods combined. Sterilization rates in Europe varied.
Generally, the older woman has a greater array of contraceptive methods
available to her, because her lower fecundity tends towards lower failure rate than
among younger women, and because of a reduced concern for future fertility.
Reduced fecundity may make barrier methods more acceptable to this age group,
although fear of pregnancy may be greater among older than among younger women.
Widespread use of condoms by this group suggests that consistent use coupled with
lower fecundity leads to acceptable failure rates.
Perceptions of safety proved to be even more important than perceptions of
reliability, however, in choosing a method of contraception. Both the pill and the
IUD, in particular, suffered from women's perceptions of them as either unsafe or
possibly hazardous to health.
In general, there is very little information available about contraceptive practices
among women over 40, despite the fact that such information is essential if the
contraceptive needs of this age group, which has in the past two decades undergone a
transition in attitudes and behaviour in many Western countries, are to be met
adequately.
It is also possible that contraceptives developed for the general population are
more effective than need be for older women, resulting in 'contraceptive overkill'
(Jansen, 1984). There is a need for carefully designed clinical trials of the use of certain
methods, such as the new hormonal formulae, by older women, especially as they
approach the menopause.
Women between the ages of 40 and 50 may be less fecund than younger women,
but they do not make sufficient use of contraception. Non-use of contraception
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obviously varies with several factors, including nationality, religion, age, education,
employment, marital status, and number of children. In general, however, perceptions
among this age group of the reliability of contraceptive methods are similar and quite
realistic. Similarly, perceptions of negative health effects cut across groups; these
perceptions, however, tend to be unrealistic.
The negative effects of certain methods such as oral contraceptives and IUDs are
overestimated by all age groups and in all countries studied. This suggests a general
state of misinformation that could have a major effect on choice of contraceptive
method, since health considerations are the prime motive for choosing or abandoning
a specific method. This becomes particularly important because the women in this age
group do not necessarily exclude a future, planned pregnancy. In view of indications
that many Western countries, including the United States, are currently seeing a trend
towards delayed childbearing (Francis, 1985), the use of reversible contraception
must be considered too low.
The controversy surrounding pill use in older women is not likely to be resolved in
the near future, however. Women who have done well on oral contraceptives in the
past will probably continue to do so as they approach the menopause (Taubert, 1985).
Women who have not done well on them will not wish to adopt this method later in
life, particularly in view of the prevalent negative view of pill safety.
A further problem, particularly in the United States, is that a woman who wishes
to take the pill may have to change doctors in order to do so. Physicians' reluctance to
prescribe the pill for older women may well increase as medical litigation increases.
The problem of diminishing availability in the United States is also a critical one
for IUDs, almost all of which have been withdrawn from the market by
manufacturers who see no commercial value for their product in a highly litigious
climate (Forrest, 1986). There is likely to be a three-fold increase in the risk of
unwanted pregnancies among those women unable to continue IUD use (Forrest,
1986). There is already some evidence that those women in the United States who can
afford to do so are crossing the border into Canada to obtain IUDs or are seeking
them in Europe. Some women who are due to have their IUDs replaced will elect to
keep them in place, which may cause problems. Research is needed to show whether
the IUD's effectiveness declines more or less quickly than its wearer's fecundity after
age 40.
Sterilization is a readily available, risk-free method of contraception for those
women who have decided that they do not want (further) children. However, women
increasingly willing to consider the idea of later pregnancies should have a better
understanding of the risk of natural methods and of the nature of the health risks
associated with reversible methods. Women and their physicians should be made
aware of improvements in IUD design and of the lowering of hormone levels in oral
contraceptives so that they can make contraceptive choices on the basis of realistic
factors rather than unfounded fears.
Moreover, the implications of widespread misinformation go beyond the women
surveyed. The under-utilization of contraception and the lack of knowledge
concerning contraceptive methods not only pose a risk to the women involved but
present an on-going hazard: women in the age group under discussion frequently
have teenage children, and several studies have shown that teenagers depend heavily
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on family members or friends for advice about contraception (Riphagen et ai, 1984,
1985a,b, 1986a,b).
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